0 CHECKOUT

PRODUCT FILTERS

REGION

1,003
92
66
63
53

COUNTRY

60
13
11
8
6

CATEGORIES

  • 73
  • 124
  • 59
  • 54
  • 35
  • 33
  • 10
  • 10
  • 11
  • 14

PRICE

547
802
1,660
2,764

PUBLISHED

63
229
599
2,764

PRODUCT TYPE

2,657
87
7
6
2
2
2
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

2,764 Products

Nasopharyngeal Carcinoma: Management Strategies

The past three decades have seen remarkable changes in the staging and treatment of this disease. Landmark clinical trials established the role of concurrent chemotherapy, to be given simultaneously...

Published:  August 2014
Price: 

Chemotherapy Induced Anemia - Pipeline Review, H2 2014

Chemotherapy Induced Anemia - Pipeline Review, H2 2014 Summary This, ‘Chemotherapy Induced Anemia - Pipeline Review, H2 2014’, provides an overview of the Chemotherapy Induced Anemia’s therapeutic...

Published:  August 2014
Price:  From

OpportunityAnalyzer: Non-Hodgkin's B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018

OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018 Summary The competitive landscape in the B-cell NHL markets in the US, France, Italy, Germany, Spain...

Published:  August 2014
Price:  From

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023 Summary Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted tubule,...

Published:  August 2014
Price:  From

Colon Carcinoma - Pipeline Review, H2 2014

Colon Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Colon Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Colon Carcinoma’s therapeutic pipeline. This report provides comprehensive...

Published:  August 2014
Price:  From

Thyroid Cancer: Disease and Pipeline Analysis

This report offers a unique therapeutic assessment and in-depth market and pipeline analysis, providing a view of the thyroid cancer market not available elsewhere. This report gives an overview of...

Published:  August 2014
Price:  From

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

This report provides in-depth analysis of the Glioblastoma Multiforme (GBM) therapeutics market within the Asia-Pacific (APAC) region, covering Australia, China, India and Japan. The report provides...

Published:  August 2014
Price:  From

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition In nine best-selling editions, Shara Rosen (MBA, RT), has created authoritative market estimates and forecasted growth models...

Published:  August 2014
Price:  From
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition - Product Thumbnail Image

Global Cancer Generics Market Outlook 2018

With the advent of novel and innovative technologies, industries like healthcare and pharmaceutical are scaling newer heights. One such market is the oncology market. With global cancer incidences rising...

Published:  August 2014
Price:  From

Global Breast Cancer Market Report: 2014 Edition

Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location....

Published:  August 2014
Price:  From

Advances in the Management of Peritoneal Carcinomatosis

Peritoneal carcinomatosis is a frequent manifestation in the natural history of many gastrointestinal and gynecological cancers. The primary tumors will exfoliate many cancer cells, these cells will...

Published:  August 2014
Price: 

Antiangiogenesis in Cancer Therapy

Angiogenesis is considered one of the hallmarks of cancer. However, barring a few notable examples of significant success such as in clear-cell kidney cancer, angiogenesis inhibition as monotherapy...

Published:  August 2014
Price: 

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

The value of the Non-Small Cell Lung Cancer (NSCLC) market is expected to increase significantly over the forecast period across the leading eight developed nations, from $5 1 billion in 2013 to $7...

Published:  July 2014
Price:  From

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Exceptionally Large and Innovative Pipeline: The breast cancer pipeline is the largest in the pharmaceutical industry with 815 products in active development across all stages. The range of mechanisms...

Published:  July 2014
Price:  From

Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2014

Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Neuro Endocrine (Carcinoid)...

Published:  July 2014
Price:  From

Rectal Cancer - Pipeline Review, H2 2014

Rectal Cancer - Pipeline Review, H2 2014 Summary This, ‘Rectal Cancer - Pipeline Review, H2 2014’, provides an overview of the Rectal Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  July 2014
Price:  From

Ewing Sarcoma - Pipeline Review, H2 2014

Ewing Sarcoma - Pipeline Review, H2 2014 Summary This, ‘Ewing Sarcoma - Pipeline Review, H2 2014’, provides an overview of the Ewing Sarcoma’s therapeutic pipeline. This report provides comprehensive...

Published:  July 2014
Price:  From

Metastatic Liver Cancer - Pipeline Review, H2 2014

Metastatic Liver Cancer - Pipeline Review, H2 2014 Summary This, ‘Metastatic Liver Cancer - Pipeline Review, H2 2014’, provides an overview of the Metastatic Liver Cancer’s therapeutic pipeline. This...

Published:  July 2014
Price:  From

Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2014

Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2014 Summary This, ‘Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2014’, provides an overview of the Opioid-Induced Constipation (OIC)’s...

Published:  July 2014
Price:  From

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2014

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2014 Summary This, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2014’, provides an overview of the Squamous Non-Small Cell Lung...

Published:  July 2014
Price:  From
Loading Indicator

Our Clients